Council & Enhanced Tennessee Fund
VC Fund
Nashville, United States
Council & Enhanced Tennessee Fund is a VC fund in Nashville focused on Medical and Software. Council & Enhanced Tennessee Fund, LLC (C&E) is a Nashville-based investment partnership focused on building transformational companies in Tennessee, including seed and early-stage businesses, and has a generalist approach to investing. Council Capital and Enhanced Capital Partners established C&E to partner with entrepreneurs inpursuing innovative, high growth market opportunities. The management teams of each of our portfolio companies expect us to be actively engaged partners, and have access to the talents and resources of our broad network.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Council & Enhanced Tennessee Fund invests in
Stages Council & Enhanced Tennessee Fund invests in
Countries Council & Enhanced Tennessee Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Rick Apple
|
|||
Investment Focus
Industry
- Medical 2 (33%)
- Software 2 (33%)
- Health Care 2 (33%)
- SaaS 1 (17%)
- Hospital 1 (17%)
Stage
- Series C 2 (33%)
- Funding Round 2 (33%)
- Seed 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Rick Apple
Director
|
Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NuScriptRx
|
Based in Nashville, Tenn., NuScriptRX is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and their patients. The company was developed by long-term care professionals who have more than 100 years of experience in SNFs, ALFs and RCs. | $8.5M / Jun 11, 2013 | |
|
NuScriptRx
|
Based in Nashville, Tenn., NuScriptRX is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and their patients. The company was developed by long-term care professionals who have more than 100 years of experience in SNFs, ALFs and RCs. | $1.9M / Mar 01, 2013 | |
ReDoc Software
|
For nearly two decades, ReDoc Software, leads the market in therapy documentation and management solutions. Our solutions are designed specifically for Physical Therapy (PT), Occupational Therapy (OT) and Speech-Language Pathology (SLP) to complement every aspect of today's dynamic therapy workflow. We make documentation simple, whilefacilitating optimal reimbursement as well as Medicare, and JCAHO compliance. Our line of ReDoc products is designed to address the clinical documentation and business needs of PTs, OTs and SLP's throughout the continuum of care. Our applications are designed to interface with a multitude of other billing and larger hospital systems, to increase the efficiency, accuracy and productivity of the entire clinic. ReDoc works closely with Microsoft and the Health Level 7 (HL-7) organizations to stay current with industry standards for application development, support, and electronic exchange of information. ReDoc currently employs approximately 51 people, including nine therapists who help develop our product and train our clients to successfully implement and interface ReDoc into their clinics. We have been inducted into the Nashville Area’s Future 50 Companies Hall of Fame by the Nashville Chamber of Commerce for being one of the area’s fastest growing companies for five years in a row. | $1.1M / Seed / Jan 14, 2013 | |
Amplion Clinical Communications
|
Amplion Clinical Communications (Amplion) specializes in developing and implementing patient-care communication technology for hospitals and health systems. Founded in 1979 as Dalcon Communications and headquartered in Nashville, the company has a long and distinguished track record of technological innovation, starting in the early 1980s as aleader in offering multi-user microcomputer-based systems. In 2006, the company developed VoIP unified communications software and, in 2008, unified patient care solutions. Both efforts received national recognition and numerous industry awards. | $3.8M / Nov 12, 2012 | |
|
NuScriptRx
|
Based in Nashville, Tenn., NuScriptRX is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and their patients. The company was developed by long-term care professionals who have more than 100 years of experience in SNFs, ALFs and RCs. | $5M / Series C / Aug 27, 2012 | |
Shareholder InSite
|
Shareholder InSite provides powerful Software as a Service (SaaS) solutions to help private companies and Venture Capital and Private Equity investors better track, manage, and analyze shareholder data. Through its team of financial and software professionals (based in Nashville, TN and Boulder, CO), Shareholder InSite offers the premiershareholder administration and transaction analysis software to leading VC/PE firms including August Capital, Benchmark Capital, Third Rock Ventures and client portfolio companies across a wide spectrum of industries. | $4.3M / Series C / Aug 14, 2012 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Council & Enhanced Tennessee Fund invest in?
Council & Enhanced Tennessee Fund invests primarily in Medical, Software and Health Care startups, most often at Series C and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Council & Enhanced Tennessee Fund?
Public channels for Council & Enhanced Tennessee Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Council & Enhanced Tennessee Fund?
The team at Council & Enhanced Tennessee Fund includes Rick Apple (Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
